Reagents and use of echo lumena analyzer for blood bank - base period: 1 OCT 2022 - 30 SEP 2023
Active Purchase Order Awarded Last action
- Contract number
- W81K0222P0068
- Awardee
-
Werfen USA LLC UEI JA87HT8KP2M2
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $1,375,481
Award facts
- Opportunity
-
- Immucor Echo Lumena Reagents and Supplies Pre-Solicitation · W81K0222Q0078 · Posted Apr 27, 2022
- Contract value 81% obligated
- $1,704,711.62 Current and potential, with all options
- Completion date 82% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Peachtree Corners, GA 30071, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $386,584 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | -$9,554 | |
| Vendor DUNS or Name Change - Non-Novation | $0 | |
| Supplemental Agreement for work within scope | $386,244 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | -$160,296 | |
| Funding Only Action | $386,252 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $386,252 | |
| Original award | $0 |
Show all 15
About this award
The Defense Health Agency awarded a purchase order to Werfen USA LLC for immunohematology reagents and use of an Echo Lumena analyzer for blood bank services, valued at $1,762,064.31, effective October 1, 2022. The base period runs from October 1, 2022 through September 30, 2023, with an ultimate completion date of September 30, 2027. Work is performed in Peachtree Corners, Georgia. The order, issued under FAR Part 12 commercial-item procedures on a firm fixed-price basis, originated from a pre-solicitation notice posted April 27, 2022. The procurement calls for blood typing, antibody determination, donor-recipient cross-matching, and identification of unexpected antibodies to prevent transfusion reactions using the specified analyzer platform.
Quick answers
Who was awarded contract W81K0222P0068?
W81K0222P0068 was awarded to Werfen USA LLC by Defense Health Agency (Department of Defense) on October 1, 2022.
How much is contract W81K0222P0068 worth?
The government has obligated $1,375,481 on W81K0222P0068. Its current value, with exercised options, is $1,704,712.
Was contract W81K0222P0068 competed?
The extent of competition for W81K0222P0068 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award